GLP-1 Fast Melts$75.00PriceFlavor*Salted CaramelSwiss Chocolate CaramelQuantity*Add to CartBoost your weight loss journey
The SURMOUNT trials reported that approximately 4 to 7% of participants discontinued due to adverse events, depending on dose level
Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to AOD-9604 research
February 2025: Novo Nordisk announced that semaglutide 2.4 mg would be available in Mexican pharmacies by April 2025, with an average 17.5% weight loss observed in pivotal trials
Heartburn and reflux symptoms appear to occur in a subset of patients, though exact prevalence rates vary depending on the trial population and reporting methods
stage 2, metabolic risk factors (those with hypertension, hypertriglyceridemia, metabolic syndrome, or type 2 diabetes mellitus) or early CKD